Zydus Lifesciences Q4 Results
- BSE: 532321
- NSE: ZYDUSLIFE
- ISIN: INE010B01027
- Sector: Biotechnology & Drugs
BSE
962.7
14.00 (1.48%)
14.00 (1.48%)Volume16.80 K
Updated: Mon 25 Nov, 2024 | 15:29:56
NSE
964.3515.30 (1.61%)
15.30 (1.61%)Volume2.66 M
Updated: Mon 25 Nov, 2024 | 15:44:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Zydus Lifesciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 5,533.80 | 4,362.30 | -% | 4,667.70 | -% |
| Selling/ General/ Admin Expenses Total | 837.00 | 689.00 | -% | 723.90 | -% |
| Depreciation/ Amortization | 205.30 | 181.60 | -% | 178.60 | -% |
| Other Operating Expenses Total | 1,460.10 | 1,206.90 | -% | 1,276.60 | -% |
| Total Operating Expense | 4,113.90 | 3,587.90 | -% | 4,476.40 | -% |
| Operating Income | 1,419.90 | 774.40 | -% | 191.30 | -% |
| Net Income Before Taxes | 1,547.00 | 780.10 | -% | 485.80 | -% |
| Net Income | 1,182.30 | 622.90 | -% | 296.60 | -% |
| Diluted Normalized EPS | 11.66 | 6.15 | -% | 7.22 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST